Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
This clinical trial aims to characterize radiologic features of rheumatoid arthritis-associated interstitial lung disease on chest high-reso…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
A Phase 3 trial evaluating BI 1015550 for improving lung function in idiopathic pulmonary fibrosis has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease [Phase 2]
A Phase 2 clinical trial evaluating senicapoc in patients with worsening fibrotic interstitial lung disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Prognostic Score Comparison in IPF and HP
A completed clinical trial compares prognostic scoring methods in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis (interstiti…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Idiopathic Pulmonary Fibrosis Cohort of TCM
Clinical trial update for an idiopathic pulmonary fibrosis cohort using traditional Chinese medicine. The study is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-09-05EMA Authorised: Nintedanib Viatris (nintedanib) — Viatris Limited
The European Medicines Agency authorised a generic version of nintedanib (Nintedanib Viatris) for idiopathic pulmonary fibrosis and related …
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Assessment of Self-Care in Patients With Idiopathic Pulmonary Fibrosis (IPF)
This clinical trial update describes an ongoing study assessing self-care in patients with idiopathic pulmonary fibrosis, which is currently…
-
EMA approval · 2025-08-29EMA Authorised: Nintedanib Accord (nintedanib) — Accord Healthcare S.L.U.
The EMA authorised Nintedanib Accord for indications including Idiopathic Pulmonary Fibrosis, interstitial lung diseases, systemic sclerosis…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial update evaluating SC01009 menstrual blood-derived mesenchymal stem cell injections for idiopathic pulmonary fibrosis,…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib
A clinical trial update from Taiwan reports long-term outcomes for people with progressive fibrosing interstitial lung diseases who started …
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 multinational trial evaluating the efficacy and safety of inhaled treprostinil in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD). [Phase 1]
Phase 1 study in idiopathic pulmonary fibrosis assessed safety, tolerability, and pharmacokinetics of a monoclonal antibody. The trial is co…
-
FDA approval · 2025-08-11FDA Approved: PIRFENIDONE — Original Application (Aurobindo Pharma Limited)
FDA approves the original ANDA for pirfenidone from Aurobindo Pharma Limited, making a generic version of the treatment for idiopathic pulmo…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF [Phase 1]
A Phase 1 PET imaging study of PIPE-791 in healthy volunteers and individuals with idiopathic pulmonary fibrosis and multiple sclerosis has …
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of DWN12088 in patients with idiopathic pulmonary fibrosis and is currently r…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF [NA]
Clinical trial update for Jin-shui Huan-xian Formula to slow pulmonary function decline in idiopathic pulmonary fibrosis; the study is not y…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 randomized, double-blind study of Bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients [Phase 1]
A Phase 1 trial evaluating the investigational therapy LTI-03 in newly diagnosed Idiopathic Pulmonary Fibrosis has completed enrollment and …
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Dose Reduction and Discontinuation With Anti-Fibrotic Medications
A completed Boehringer Ingelheim trial update evaluating dose reduction and discontinuation patterns with anti-fibrotic therapy in idiopathi…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
An update on the PaTH Clinical Data Research Network Idiopathic Pulmonary Fibrosis Clinician-Patient Partnership Cohort, with the study list…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: IPF mHealth Exercise Study [NA]
A completed clinical trial from the University of Washington evaluating an mHealth-based exercise program for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 clinical trial is evaluating molecular imaging probes to inform heterogeneity in idiopathic pulmonary fibrosis. Sponsored by the U…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis [EARLY_Phase 1]
An early-phase 1 clinical trial at the University of Virginia is evaluating hyperpolarized Xenon-129 MRI as an imaging approach for idiopath…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected Cases
A clinical trial update assessing the diagnostic performance of high-resolution CT (HRCT) for suspected idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Cough Reduction in IPF With Nalbuphine ER [Phase 2]
Trevi Therapeutics completed a Phase 2 trial of nalbuphine extended-release for cough reduction in idiopathic pulmonary fibrosis.